CLINICAL_TRIALS
trial_result
· 2021-09-28
Clinical Trial Update: Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty [Phase 4]
Summary
Phase 4 clinical trial evaluating tranexamic acid (TXA) in total joint arthroplasty was terminated; results posted previously.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Blood Loss | Phase 4 | Status: TERMINATED | Results posted: 2021-09-28